These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25425957)

  • 1. Global Efforts against HIV Epidemic and HIV Vaccine Development.
    Tanuma J
    Trop Med Health; 2014 Jun; 42(2 Suppl):91-2. PubMed ID: 25425957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from HIV vaccine clinical efficacy trials.
    Day TA; Kublin JG
    Curr HIV Res; 2013 Sep; 11(6):441-9. PubMed ID: 24033299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling HIV Pre-Exposure Prophylaxis.
    Straubinger T; Kay K; Bies R
    Front Pharmacol; 2019; 10():1514. PubMed ID: 32082142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical strategies for human immunodeficiency virus (HIV) prevention? A new paradigm.
    Chan R
    Ann Acad Med Singap; 2012 Dec; 41(12):595-601. PubMed ID: 23303118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV vaccine research: the challenge and the way forward.
    Wang HB; Mo QH; Yang Z
    J Immunol Res; 2015; 2015():503978. PubMed ID: 25861656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent update in HIV vaccine development.
    Shin SY
    Clin Exp Vaccine Res; 2016 Jan; 5(1):6-11. PubMed ID: 26866018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Vaccine Efficacy Trials: RV144 and Beyond.
    Heger E; Schuetz A; Vasan S
    Adv Exp Med Biol; 2018; 1075():3-30. PubMed ID: 30030787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.
    Li J; Dufrene SL; Okulicz JF
    Ann Pharmacother; 2014 Apr; 48(4):507-18. PubMed ID: 24473492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved outlook on HIV-1 prevention and vaccine development.
    Vasan S; Michael NL
    Expert Opin Biol Ther; 2012 Aug; 12(8):983-94. PubMed ID: 22583109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ; Bulled N
    Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Evans C; Hoverman A; Sun C; Dana T; Bougatsos C; Grusing S; Korthuis PT
    JAMA; 2019 Jun; 321(22):2214-2230. PubMed ID: 31184746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective HIV vaccine: A combination of humoral and cellular immunity?
    Benmira S; Bhattacharya V; Schmid ML
    Curr HIV Res; 2010 Sep; 8(6):441-9. PubMed ID: 20636279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.
    Koff WC; Russell ND; Walport M; Feinberg MB; Shiver JW; Karim SA; Walker BD; McGlynn MG; Nweneka CV; Nabel GJ
    Vaccine; 2013 Apr; 31 Suppl 2():B204-8. PubMed ID: 23598483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where next with preexposure prophylaxis?
    Nugent D; Gilson R
    Curr Opin Infect Dis; 2017 Feb; 30(1):44-49. PubMed ID: 27870645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current views on the potential for development of a HIV vaccine.
    Cohen KW; Frahm N
    Expert Opin Biol Ther; 2017 Mar; 17(3):295-303. PubMed ID: 28095712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions.
    McNicholl JM
    Hum Vaccin Immunother; 2016 Dec; 12(12):3202-3211. PubMed ID: 27679928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.